Expert consensus on the management of breakthrough cancer pain in older patients. A Delphi study


Por: Alarcon M, Estevez F, Cabezon-Gutierrez L, Padros M, Martin-Arroyo J, Rebollo M, Jimenez-Lopez A, Sanz-Yague A

Publicada: 1 jul 2019
Resumen:
Objectives: We aimed to generate expert-based recommendations on the management of breakthrough cancer pain (BTcP) in older patients with cancer. Material and Methods: A two-round multidisciplinary Delphi study. Specialists rated their agreement with a set of statements using a nine-point Likert scale (one = totally disagree and nine = totally agree). Statements were classified as appropriate (median ranged from seven to nine), irrelevant (median ranged from four to six) or inappropriate (median ranged from one to three). Consensus was established when at least two thirds of the panel scored within any of the ranges. Results: A total of 64 specialists from pain units (44.4%), palliative care units (25.4%), medical oncology (19.1%), geriatric medicine (7.9%) and others (3.2%), participated in two consultation rounds, Specialists agreed that effective coordination between the different specialties and levels of care is essential for proper management of BTcP. Most participants (81.3%) supported the assessment of frailty and resolved (96.8%) that frailty status is a better indicator of patient needs than biological age. Participants agreed (75.8%) in the application of the Davies algorithm for diagnosis of BTcP in older patients. A strong consensus was achieved regarding which pharmacological treatment (transmucosal fentanyl) and dosing method (start low and go slow) are the most suitable for the older population. No agreement was reached on how interventionist techniques should be integrated into the therapeutic strategy for BTcP. Conclusions: The present Delphi has generated a set of recommendations that will help healthcare professionals in the management of BTcP in older patients. (C) 2019 Published by Elsevier Ltd.

Filiaciones:
Alarcon M:
 Hosp Gen Univ Valencia, Ave Tres Cruces 2, Valencia 46014, Spain

Estevez F:
 Consorcio Hosp Prov Castellon, Ave Dr Clara 19, Castellon de La Plana 12002, Spain

Cabezon-Gutierrez L:
 Hosp Univ Torrejon, Calle Mateo Inurria S-N, Madrid 28850, Spain

Padros M:
 Complejo Hosp Univ Nuestra Senora Candelaria, Ctra Gral Rosario 145, Santa Cruz De Tenerife 38010, Spain

Martin-Arroyo J:
 Hosp Puerta Mar, Av Ana de Viya 21, Cadiz 11009, Spain

Rebollo M:
 Hosp Duran i Reynals, ICO, Avinguda Gran Via 199, Barcelona 08908, Spain

Jimenez-Lopez A:
 Kyowa Kirin Farmaceut, SLU, Edificio Triada,Av Burgos 17, Madrid 28036, Spain

Sanz-Yague A:
 Kyowa Kirin Farmaceut, SLU, Edificio Triada,Av Burgos 17, Madrid 28036, Spain
ISSN: 18794068





Journal of Geriatric Oncology
Editorial
Elsevier BV, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS, Países Bajos
Tipo de documento: Article
Volumen: 10 Número: 4
Páginas: 643-652
WOS Id: 000473118500021
ID de PubMed: 31036463

MÉTRICAS